A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
NiKang Therapeutics, Inc.
NiKang Therapeutics, Inc.
Pfizer
Karyopharm Therapeutics Inc
DL Analytics
Yuri Semenyuk Rivne Regional Clinical Hospital
Endeavor Health
NiKang Therapeutics, Inc.
University of Minnesota
Johns Hopkins University
Karolinska Institutet
Mabwell (Shanghai) Bioscience Co., Ltd.
Elucida Oncology
Federico II University
Advaxis, Inc.
Kaiser Permanente
Imperial College London
National Institutes of Health Clinical Center (CC)
Belgian Gynaecological Oncology Group
Genexine, Inc.
Novartis
Campus Bio-Medico University
GlaxoSmithKline